RSNA 2008 

Abstract Archives of the RSNA, 2008


VI11-08

Ablation for Hepatocellular Carcinoma: Patient and Lesion Selection to Optimize Outcomes

Multisession Courses

Presented on November 30, 2008
Presented as part of VI11: Interventional Oncology Series: Hepatocellular Carcinoma

Participants

David Shin-Kuo Lu MD, Presenter: Consultant, Siemens AG Consultant, Vital Images, Inc Consultant, General Electric Company Speaker, General Electric Company Speaker, Boston Scientific Corporation Consultant, Endocare, Inc Research funded, Endocare, Inc Consultant, Covidien AG Speaker, Covidien AG Research funded, Covidien AG

LEARNING OBJECTIVES

1) Understand the patient selection issues for ablation versus other therapy. 2) Learn how patient factors affect ablation outcome. 3) Learn how turmor characteristics affect ablation outcome. 4) Learn the literature evidence for practice guidelines above.

Cite This Abstract

Lu, D, Ablation for Hepatocellular Carcinoma: Patient and Lesion Selection to Optimize Outcomes.  Radiological Society of North America 2008 Scientific Assembly and Annual Meeting, February 18 - February 20, 2008 ,Chicago IL. http://archive.rsna.org/2008/6007092.html